InnoCan Pharma Corporation INNPF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 39.15% | -133.28% | 38.71% | -24.20% | 63.69% |
| Total Depreciation and Amortization | 5.88% | 14.29% | 20.00% | -2.70% | -8.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -301.13% | -214.49% | -144.94% | 1.80% | -64.01% |
| Change in Net Operating Assets | 1,053.85% | 363.34% | 275.66% | 178.75% | 123.45% |
| Cash from Operations | -237.31% | 18.32% | 131.35% | 123.97% | 78.44% |
| Capital Expenditure | -18.75% | 38.89% | -6.67% | 30.00% | -14.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -98.55% | -100.00% | -98.55% | -- | 315.63% |
| Cash from Investing | -133.96% | -121.15% | -127.78% | 375.00% | 215.22% |
| Total Debt Issued | 1.56% | -29.69% | -- | -- | -- |
| Total Debt Repaid | 85.00% | 66.67% | 50.00% | 19.05% | 0.00% |
| Issuance of Common Stock | -100.00% | -76.46% | -90.83% | -94.18% | -75.17% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -95.29% | -76.89% | -48.35% | -31.12% |
| Cash from Financing | -73.13% | -73.33% | -57.62% | -54.82% | -39.97% |
| Foreign Exchange rate Adjustments | -25.86% | 176.47% | 194.64% | 135.29% | 220.83% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -141.43% | -85.20% | 49.51% | 114.23% | 13.77% |